Align Technology, Inc. (ALGN) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 33 analysts11.8% Below Target
ALGN trades 11.8% below Wall Street's consensus target of $203.60.
Current Price$182.08
Average Target$203.60
Target
Current
Low$185.00
Median$200.00
High$235.00
Analyst Target Range
Forward P/E16.0x
(Fair)
PEG Ratio—
Implied Growth+89.5%
(High Growth)
Analyst Spread24.6%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes ALGN achieves its forward estimates and maintains a stable P/E multiple of 16.0x. This scenario reflects the blended consensus of 33 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
ALGN Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Align Technology, Inc. (ALGN) has a Wall Street consensus price target of $203.60, based on estimates from 33 covering analysts. With the stock currently trading at $182.08, this represents a potential upside of +11.8%. The company has a market capitalization of $13.04B.
Analyst price targets range from a low of $185.00 to a high of $235.00, representing a 25% spread in expectations. The median target of $200.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 24 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ALGN trades at a trailing P/E of 32.2x and forward P/E of 16.0x. Analysts expect EPS to grow +89.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $266.85, with bear and bull scenarios of $168.11 and $351.60 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+23.3%
Industry Consensus
Avg Forward P/E
31.7x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 XRAYDENTSPLY SIRONA Inc. | $2.1B | $10.33 | $13.33 | +29.0% | Hold | 7.3x | 31 |
 HSICHenry Schein, Inc. | $9.2B | $79.92 | $87.43 | +9.4% | Buy | 14.9x | 33 |
 NVSTEnvista Holdings Corp | $4.2B | $25.91 | $28.33 | +9.3% | Hold | 18.1x | 19 |
 IDXXIDEXX Laboratories, Inc. | $44.6B | $562.09 | $747.50 | +33.0% | Buy | 38.3x | 22 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $78.69 | +3.5% | Hold | 17.2x | 42 |
 ISRGIntuitive Surgical, Inc. | $144.5B | $406.78 | $597.78 | +47.0% | Buy | 38.9x | 55 |
 GKOSGlaukos Corporation | $7.6B | $130.68 | $151.25 | +15.7% | Buy | — | 24 |
 TMDXTransMedics Group, Inc. | $2.7B | $78.79 | $121.20 | +53.8% | Buy | 38.9x | 12 |
 MMM3M Company | $83.8B | $160.60 | $166.75 | +3.8% | Hold | 18.5x | 33 |
 IPGPIPG Photonics Corporation | $5.0B | $118.01 | $151.50 | +28.4% | Buy | 92.9x | 27 |
ALGN — Frequently Asked Questions
Quick answers to the most common questions about buying ALGN stock.
What is the ALGN stock price target for 2026?
Align Technology, Inc. (ALGN) has a consensus 12-month price target of $203.6, implying 11.8% upside from $182.08. The 33 analysts covering ALGN see moderate appreciation potential.
Is ALGN a buy, sell, or hold?
ALGN has a consensus rating of "Buy" based on 33 Wall Street analysts. The rating breakdown is predominantly bullish, with 24 Buy/Strong Buy ratings. The consensus 12-month price target of $203.6 implies 11.8% upside from current levels.
Is ALGN stock overvalued or undervalued?
With a forward P/E of 16.0084x, ALGN trades at a relatively low valuation. The consensus target of $203.6 implies 11.8% appreciation, suggesting meaningful undervaluation.
How high can ALGN stock go?
The most bullish Wall Street analyst has a price target of $235 for ALGN, while the most conservative target is $185. The consensus of $203.6 represents the median expectation. Our quantitative valuation model projects a bull case target of $352 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ALGN stock?
ALGN is heavily covered by Wall Street, with 33 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 24 have Buy ratings, 7 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ALGN stock forecast?
The 12-month ALGN stock forecast based on 33 Wall Street analysts shows a consensus price target of $203.6, with estimates ranging from $185 (bear case) to $235 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $267, with bear/bull scenarios of $168/$352.
What is ALGN's fair value based on fundamentals?
Our quantitative valuation model calculates ALGN's fair value at $267 (base case), with a bear case of $168 and bull case of $352. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
What is ALGN's forward P/E ratio?
ALGN trades at a forward P/E ratio of 16.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 32.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ALGN stock?
Wall Street analysts are optimistic on ALGN, with a "Buy" consensus rating and $203.6 price target (11.8% upside). 24 of 33 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ALGN price targets vary so much?
ALGN analyst price targets range from $185 to $235, a 25% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $203.6 consensus represents the middle ground. Our model's $168-$352 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into ALGN consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare